{"id":"https://openalex.org/W2024262153","doi":"https://doi.org/10.1002/pds.762","title":"Budesonide\u2010treated asthmatic adolescents attain target height: a population\u2010based follow\u2010up study from Sweden","display_name":"Budesonide\u2010treated asthmatic adolescents attain target height: a population\u2010based follow\u2010up study from Sweden","publication_year":2002,"publication_date":"2002-11-01","ids":{"openalex":"https://openalex.org/W2024262153","doi":"https://doi.org/10.1002/pds.762","mag":"2024262153","pmid":"https://pubmed.ncbi.nlm.nih.gov/12512249"},"language":"en","primary_location":{"id":"doi:10.1002/pds.762","doi":"https://doi.org/10.1002/pds.762","is_oa":false,"landing_page_url":"https://doi.org/10.1002/pds.762","pdf_url":null,"source":{"id":"https://openalex.org/S140231191","display_name":"Pharmacoepidemiology and Drug Safety","issn_l":"1053-8569","issn":["1053-8569","1099-1557"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacoepidemiology and Drug Safety","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059674225","display_name":"Lars Larsson","orcid":"https://orcid.org/0000-0003-3722-035X","observed_orcids":["https://orcid.org/0000-0003-3722-035X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lars Larsson","raw_affiliation_strings":["Dept of Pulmonary Medicine, Ostersund Hospital, Ostersund, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept of Pulmonary Medicine, Ostersund Hospital, Ostersund, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055336852","display_name":"Maria Gerhardsson de Verdier","orcid":"https://orcid.org/0000-0002-4029-1215","observed_orcids":["https://orcid.org/0000-0002-4029-1215"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Maria Gerhardsson de Verdier","raw_affiliation_strings":["AstraZeneca, R&D, Lund, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, R&D, Lund, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043439053","display_name":"Bertil Lindmark","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Bertil Lindmark","raw_affiliation_strings":["AstraZeneca, R&D, Lund, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, R&D, Lund, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5033820511","display_name":"Ensio Norjavaara","orcid":"https://orcid.org/0000-0003-0415-4843","observed_orcids":["https://orcid.org/0000-0003-0415-4843"]},"institutions":[{"id":"https://openalex.org/I2801112325","display_name":"Sahlgrenska University Hospital","ror":"https://ror.org/04vgqjj36","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I2801112325"]},{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":true,"raw_author_name":"Ensio Norjavaara","raw_affiliation_strings":["AstraZeneca R&D Mo\u0308lndal, Mo\u0308lndal, Sweden","Go\u0308teborg Pediatric Growth Research Center, Sahlgrenska University Hospital O\u0308stra, Go\u0308teborg, Sweden","AstraZeneca R&D M\u00f6lndal, SE\u2010431 83 M\u00f6lndal, Sweden","G\u00f6teborg Pediatric Growth Research Center, Sahlgrenska University Hospital \u00d6stra, G\u00f6teborg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca R&D Mo\u0308lndal, Mo\u0308lndal, Sweden","institution_ids":["https://openalex.org/I4210143795"]},{"raw_affiliation_string":"Go\u0308teborg Pediatric Growth Research Center, Sahlgrenska University Hospital O\u0308stra, Go\u0308teborg, Sweden","institution_ids":["https://openalex.org/I2801112325"]},{"raw_affiliation_string":"AstraZeneca R&D M\u00f6lndal, SE\u2010431 83 M\u00f6lndal, Sweden","institution_ids":["https://openalex.org/I4210143795"]},{"raw_affiliation_string":"G\u00f6teborg Pediatric Growth Research Center, Sahlgrenska University Hospital \u00d6stra, G\u00f6teborg, Sweden","institution_ids":["https://openalex.org/I2801112325"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5033820511"],"corresponding_institution_ids":["https://openalex.org/I2801112325","https://openalex.org/I4210143795"],"apc_list":{"value":4650,"currency":"USD","value_usd":4650},"apc_paid":null,"fwci":0.7618,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":{"value":0.71791531,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"11","issue":"8","first_page":"715","last_page":"720"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.9779999852180481,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.9779999852180481,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12421","display_name":"Adrenal Hormones and Disorders","score":0.005499999970197678,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10748","display_name":"Growth Hormone and Insulin-like Growth Factors","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/asthma","display_name":"asthma","score":0.9129999876022339},{"id":"https://openalex.org/keywords/inhaled-budesonide","display_name":"inhaled budesonide","score":0.8980000019073486},{"id":"https://openalex.org/keywords/glucocorticoid-therapy","display_name":"glucocorticoid therapy","score":0.7770000100135803},{"id":"https://openalex.org/keywords/adult-height","display_name":"adult height","score":0.9480000138282776},{"id":"https://openalex.org/keywords/target-height","display_name":"target height","score":0.8840000033378601},{"id":"https://openalex.org/keywords/adolescent-growth","display_name":"adolescent growth","score":0.5789999961853027},{"id":"https://openalex.org/keywords/height-prediction","display_name":"height prediction","score":0.335999995470047},{"id":"https://openalex.org/keywords/inhaled-corticosteroids","display_name":"inhaled corticosteroids","score":0.7519999742507935},{"id":"https://openalex.org/keywords/cumulative-dose","display_name":"cumulative dose","score":0.4390000104904175}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9384222030639648},{"id":"https://openalex.org/C2776136866","wikidata":"https://www.wikidata.org/wiki/Q422212","display_name":"Budesonide","level":3,"score":0.925534725189209},{"id":"https://openalex.org/C2776042228","wikidata":"https://www.wikidata.org/wiki/Q35869","display_name":"Asthma","level":2,"score":0.7518092393875122},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.5273688435554504},{"id":"https://openalex.org/C2780841215","wikidata":"https://www.wikidata.org/wiki/Q422549","display_name":"Glucocorticoid","level":2,"score":0.5199045538902283},{"id":"https://openalex.org/C2776954882","wikidata":"https://www.wikidata.org/wiki/Q840343","display_name":"Inhalation","level":2,"score":0.5190247297286987},{"id":"https://openalex.org/C105922876","wikidata":"https://www.wikidata.org/wiki/Q1423981","display_name":"Airway","level":2,"score":0.4771580100059509},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.45142027735710144},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3480255603790283},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.27608609199523926},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001249","descriptor_name":"Asthma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001827","descriptor_name":"Body Height","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011795","descriptor_name":"Surveys and Questionnaires","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013548","descriptor_name":"Sweden","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019819","descriptor_name":"Budesonide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1002/pds.762","doi":"https://doi.org/10.1002/pds.762","is_oa":false,"landing_page_url":"https://doi.org/10.1002/pds.762","pdf_url":null,"source":{"id":"https://openalex.org/S140231191","display_name":"Pharmacoepidemiology and Drug Safety","issn_l":"1053-8569","issn":["1053-8569","1099-1557"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacoepidemiology and Drug Safety","raw_type":"journal-article"},{"id":"pmid:12512249","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12512249","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacoepidemiology and drug safety","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":17,"referenced_works":["https://openalex.org/W179306428","https://openalex.org/W1583929010","https://openalex.org/W1969056025","https://openalex.org/W1978700393","https://openalex.org/W1981768470","https://openalex.org/W1996875153","https://openalex.org/W2023685434","https://openalex.org/W2024301697","https://openalex.org/W2025958643","https://openalex.org/W2047540788","https://openalex.org/W2074831168","https://openalex.org/W2096598461","https://openalex.org/W2110980418","https://openalex.org/W2117261361","https://openalex.org/W2148974655","https://openalex.org/W2152678811","https://openalex.org/W3147732162"],"related_works":["https://openalex.org/W1969056025","https://openalex.org/W2087878092","https://openalex.org/W4237279614","https://openalex.org/W2161453823","https://openalex.org/W2024301697","https://openalex.org/W2074831168","https://openalex.org/W2288168010","https://openalex.org/W2884749554","https://openalex.org/W1997422315","https://openalex.org/W1980914992"],"abstract_inverted_index":{"PURPOSE:":[0],"To":[1],"examine":[2],"final":[3,98,127,177,210],"height":[4,9,99,106,128,178,183,211],"in":[5,10,37,41,48,102,107,176,179,212],"relation":[6,103,180,213],"to":[7,33,72,93,104,181,191,214],"target":[8,105,133,182,216],"asthmatic":[11,79,109],"patients":[12,80,110,144,154],"with":[13,22,147,156,194,205],"and":[14,28,39,46,64,81,97,111,121,142,163],"without":[15,149],"glucocorticoid":[16],"treatment":[17,187],"while":[18],"growing":[19],"up":[20],"compared":[21],"healthy":[23,68,83,113],"individuals.":[24,114],"METHODS:":[25],"In":[26,87],"1990":[27],"1993,":[29],"questionnaires":[30],"were":[31,70,85,91,136],"distributed":[32],"all":[34,89],"individuals":[35,51,84],"born":[36],"1974":[38],"1977":[40],"the":[42,130,153],"counties":[43],"of":[44,54,67,152,198],"J\u00e4mtland":[45],"G\u00e4strikland":[47],"Sweden.":[49],"All":[50],"reporting":[52],"use":[53],"anti-asthmatic":[55],"drugs":[56],"or":[57,148,193],"symptoms":[58],"indicating":[59],"possible":[60],"obstructive":[61],"airway":[62],"disease,":[63],"a":[65,73,94,124,174],"sample":[66],"volunteers":[69],"invited":[71,92],"clinical":[74],"examination.":[75],"RESULTS:":[76],"Overall,":[77],"356":[78],"384":[82],"identified.":[86],"1998-1999,":[88],"subjects":[90],"follow-up":[95],"study":[96],"was":[100,116,170,188],"analysed":[101],"152":[108],"131":[112],"It":[115],"found":[117],"that":[118],"both":[119],"men":[120],"women":[122],"achieved":[123],"higher":[125],"mean":[126,132],"than":[129],"calculated":[131],"height.":[134,217],"There":[135,169],"no":[137,171],"significant":[138],"differences":[139],"between":[140],"controls":[141],"asthma":[143],"treated":[145,155,204],"either":[146],"glucocorticoids.":[150],"Most":[151],"glucocorticoids":[157],"started":[158],"their":[159,215],"therapy":[160],"during":[161],"adolescence":[162,192],"92%":[164],"had":[165],"used":[166],"inhaled":[167,185,199,206],"budesonide.":[168,200],"trend":[172],"towards":[173],"decrease":[175],"when":[184],"budesonide":[186,207],"initiated":[189],"prior":[190],"lifelong":[195],"cumulative":[196],"dose":[197],"CONCLUSIONS:":[201],"Asthmatic":[202],"adolescents":[203],"achieve":[208],"normal":[209]},"counts_by_year":[{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}